Open Market Insider Transactions by Quarter at Regeneron Pharmaceuticals, Inc. (REGN)
This page shows insider transactions made on REGN shares by quarter that have been filtered to include only transactions with the codes "P" and "S". These codes refer to open market or private purchases and sales, respectively. If you would like to learn more about these codes and how they relate to Form 4 transactions, you can read more about them here.
Shares Bought
Shares Sold
REGN Insider transactions
| Quarter | Buy / Adquisition | Sell / Disposition | Net Activity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Traded Shares | Avg. Price /p share | Transactions | Insiders | Traded Shares | Avg. Price /p share | Transactions | Insiders | |||
| Q4 2024 | — | 2.1K | $1039.16 $2.18 Million | 19 | 2 | (2.1K) | ||||
| Q3 2024 | — | 35.5K | $1121.9 $39.8 Million | 118 | 9 | (35.5K) | ||||
| Q2 2024 | — | 193K | $965.8 $186 Million | 113 | 7 | (193K) | ||||
| Q1 2024 | — | 79.9K | $950.08 $75.9 Million | 117 | 12 | (79.9K) | ||||
| Q4 2023 | — | 23.6K | $820.63 $19.3 Million | 60 | 7 | (23.6K) | ||||
| Q3 2023 | — | 33K | $781.02 $25.8 Million | 45 | 7 | (33K) | ||||
| Q2 2023 | — | 4.72K | $783.75 $3.7 Million | 27 | 3 | (4.72K) | ||||
| Q1 2023 | — | 38.8K | $779.2 $30.3 Million | 84 | 8 | (38.8K) | ||||
| Q4 2022 | — | 49.2K | $742.39 $36.5 Million | 125 | 10 | (49.2K) | ||||
| Q3 2022 | — | 77.2K | $641.46 $49.5 Million | 86 | 9 | (77.2K) | ||||
| Q2 2022 | — | 28K | $690.43 $19.4 Million | 87 | 7 | (28K) | ||||
| Q1 2022 | — | 80.2K | $638.57 $51.2 Million | 94 | 13 | (80.2K) | ||||
| Q4 2021 | — | 43.8K | $640.23 $28.1 Million | 110 | 7 | (43.8K) | ||||
| Q3 2021 | — | 436K | $631.41 $275 Million | 184 | 17 | (436K) | ||||
| Q2 2021 | — | 105K | $529.61 $55.8 Million | 27 | 6 | (105K) | ||||
| Q1 2021 | — | 2.68K | $494.66 $1.33 Million | 23 | 2 | (2.68K) | ||||
| Q4 2020 | — | 17.1K | $546.67 $9.37 Million | 50 | 4 | (17.1K) | ||||
| Q3 2020 | — | 1K | $612.15 $612,150 | 1 | 1 | (1K) | ||||
| Q2 2020 | — | 22.9M | $539.06 $12.4 Billion | 3 | 1 | (22.9M) | ||||
| Q1 2020 | — | 129K | $489.65 $63.1 Million | 1 | 1 | (129K) | ||||
| Q3 2019 | — | 173K | $281.15 $48.6 Million | 1 | 1 | (173K) | ||||
| Q1 2019 | — | 131K | $412.17 $54 Million | 1 | 1 | (131K) | ||||
| Q3 2018 | — | 105K | $406.68 $42.5 Million | 1 | 1 | (105K) | ||||
| Q2 2018 | — | 122K | $309.31 $37.6 Million | 1 | 1 | (122K) | ||||
| Q3 2017 | 239K | $481.55 $115 Million | 28 | 1 | — | 239K | ||||
| Q2 2017 | 136K | $475.63 $64.7 Million | 15 | 1 | — | 136K | ||||
| Q1 2017 | 87.3K | $371.01 $32.4 Million | 18 | 1 | — | 87.3K | ||||
| Q2 2016 | 64.7K | $364.22 $23.6 Million | 7 | 1 | — | 64.7K | ||||
| Q1 2016 | 245K | $429.07 $105 Million | 35 | 1 | — | 245K | ||||
| Q4 2015 | 91.6K | $462.91 $42.4 Million | 27 | 1 | — | 91.6K | ||||
| Q3 2015 | 158K | $533.86 $84.3 Million | 28 | 1 | — | 158K | ||||
| Q4 2014 | 482K | $359.67 $173 Million | 44 | 1 | — | 482K | ||||
| Q3 2014 | 1.91M | $313.61 $598 Million | 105 | 1 | — | 1.91M | ||||
| Q2 2014 | 453K | $285.35 $129 Million | 24 | 1 | — | 453K | ||||
| Q1 2014 | 3.59M | $310.38 $1.11 Billion | 211 | 1 | — | 3.59M | ||||
| Q4 2010 | 1.02M | $28.0 $28.5 Million | 1 | 1 | — | 1.02M | ||||